Dr. Schumacher India Profile
Key Indicators
- Authorised Capital ₹ 5.54 Cr
- Paid Up Capital ₹ 5.54 Cr
- Company Age 10 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth -33.41%
- Profit Growth -49.52%
- Ebitda -42.01%
- Net Worth 20.72%
- Total Assets 1.07%
About Dr. Schumacher India
Dr. Schumacher India Private Limited (DSIPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 19 September 2014 and has a history of Ten years and four months. Its registered office is in Pune, Maharashtra, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.54 Cr and a paid-up capital of Rs 5.54 Cr, as per Ministry of Corporate Affairs (MCA) records.
Ulf Meyen, Hans Orlick, and Dierk Schumacher serve as directors at the Company.
Company Details
-
Location
Pune, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U24132PN2014PTC152604
-
Company No.
152604
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
19 Sep 2014
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Pune
Industry
What products or services does Dr. Schumacher India Private Limited offer?
Dr. Schumacher India Private Limited offers a wide range of products and services, including Adhesives, Glue and Sealants, Packaging Adhesives.
Who are the key members and board of directors at Dr. Schumacher India?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ulf Meyen
|
Director | 15-Oct-2024 | Current |
|
Hans Orlick
|
Director | 19-Sep-2014 | Current |
|
Dierk Schumacher
|
Director | 19-Jan-2023 | Current |
Financial Performance of Dr. Schumacher India.
Dr. Schumacher India Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 33.41% decrease. The company also saw a substantial fall in profitability, with a 49.52% decrease in profit. The company's net worth Soared by an impressive increase of 20.72%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Dr. Schumacher India?
In 2023, Dr. Schumacher India had a promoter holding of 99.86% and a public holding of 0.14%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Dr. Schumacher India?
Unlock and access historical data on people associated with Dr. Schumacher India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dr. Schumacher India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dr. Schumacher India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED.webp){kind=small}
